Pneumonectomy due to lung cancer results in a more pronounced activation of coagulation system than lobectomy

European Journal of Cardio-thoracic Surgery

Volumn 36, Issue 6, 2009, Pages 1064-1068

  Świniarska, Joanna ^a   Zekanowska, Ewa ^b   Dancewicz, Maciej ^a,b   Bella, Mariusz ^a,b   Szczesny, Tomasz Jaroslaw ^a   Kowalewski, Janusz ^a,b  

^a Oncology Center Bydgoszcz   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Lobectomy; Lung cancer; Pneumonectomy; Thrombo embolic complications

Indexed keywords

BLOOD CLOTTING FACTOR 10; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENOXAPARIN; L SELECTIN; PADGEM PROTEIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CANCER STAGING; CLINICAL ARTICLE; COMPRESSION GARMENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; LUNG ADENOCARCINOMA; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; LYMPHADENECTOMY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANK SUM TEST; THROMBOSIS; THROMBOSIS PREVENTION; TUMOR LOCALIZATION;

AGED; ANTITHROMBIN III; BLOOD COAGULATION; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LIPOPROTEINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PNEUMONECTOMY; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; SELECTINS; THROMBOPLASTIN;

EID: 70449528516     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.04.070     Document Type: Article

References (23)

1. Kalweit G., Huwer H., Volkmer I., Petzold T., and Gams E. Pulmonary embolism: a frequent cause of acute fatality after lung resection. Eur J Cardiothorac Surg 10 4 (1996) 242-246
2. Sakuragi T., Sakao Y., Furukawa K., Rikitake K., Ohtsubo S., Okazaki Y., Natsuaki M., and Itoh T. Successful management of acute pulmonary embolism after surgery for lung cancer. Eur J Cardiothorac Surg 24 4 (2003) 580-587
3. Stamatis G., Djuric D., Eberhardt W., Pöttken C., Zaboura G., Fechner S., and Fujimoto T. Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated patients. Eur J Cardiothorac Surg 22 2 (2002) 292-297
4. Ziomek S., Read R.C., Tobler H.G., Harrell Jr. J.E., Gocio J.C., Fink L.M., Ranval T.J., Ferris E.J., Harshfield D.L., McFarland D.R., Schaefer R.F., Purnel G.L., and Barnes R.W. Thromboembolism in patients undergoing thoracotomy. Ann Thorac Surg 56 2 (1993) 223-226
5. Lyman G.H., Khorana A.A., Falanga A., Clarke-Pearson D., Flowers C., Jahanzeb M., Kakkar A., Kuderer N.M., Levine M.N., Liebman H., Mendelson D., Raskob G., Somerfield M.R., Thodiyil P., Trent D., Francis C.W., and American Society of Clinical Oncology. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 25 34 (2007) 490-505
6. Agnelli G., Bolis G., Capussotti L., Scarpa R.M., Tonelli F., Bonizzoni E., Moia M., Parazzini F., Rossi R., Sonaglia F., Valarani B., Bianchini C., and Gussoni G. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 243 1 (2006) 89-95
7. Bezeaud A., Denninger M.H., Dondero F., Saada V., Venisse L., Huisse M.G., Belghiti J., and Guillin M.C. Hypercoagulability after partial liver resection. Thromb Haemost 98 6 (2007) 1252-1256
8. Iversen L.H., and Thorlacius-Ussing O. Relationship of coagulation test abnormalities to tumour burden and postoperative DVT in resected colorectal cancer. Thromb Haemost 87 3 (2002) 402-408
9. Kakkar A.K., Haas S., Wolf H., and Encke A. Evaluation of perioperative fatal pulmonary embolism and death in cancer surgical patients: the MC-4 cancer substudy. Thromb Haemost 94 4 (2005) 867-871
10. Kameyama K., Huang C.L., Liu D., Okamoto T., Hayashi E., Yamamoto Y., and Yokomise H. Pulmonary embolism after lung resection: diagnosis and treatment. Ann Thorac Surg 76 2 (2003) 599-601
11. Szczepański M., Szostek P., Pypno W., and Borówka A. The lack of effect of a prophylactic dose of enoxaparin on thrombin generation in patients subjected to nephrectomy because of kidney cancer. Thromb Res 104 6 (2001) 427-432
12. Kilic D., Akin S., Findikcioglu A., Bilen A., Aribogan A., and Hatipoglu A. Low-molecular-weight heparin for treatment of submassive pulmonary embolism after pneumonectomy. Gen Thorac Cardiovasc Surg 55 7 (2007) 287-289
13. Ferrigno D., Buccheri G., and Ricca I. Prognostic significance of blood coagulation tests in lung cancer. Eur Respir J 17 4 (2001) 667-673
14. Goldin-Lang P., Tran Q.V., Fichtner I., Eisenreich A., Antoniak S., Schulze K., Coupland S.E., Poller W., Schultheiss H.P., and Rauch U. Tissue factor expression pattern in human non-small cell lung cancer tissues indicate increased blood thrombogenicity and tumor metastasis. Oncol Rep 20 1 (2008) 123-128
15. Marinho F.C., and Takagaki T.Y. Hypercoagulability and lung cancer. J Bras Pneumol 34 5 (2008) 312-322
16. Andersen B.S., Rahr H.B., and Sørensen J.V. Determination of coagulation inhibitor levels and resistance to activated protein C in patients undergoing gastric surgery for benign and malignant disorders. Haemostasis 27 4 (1997) 157-162
17. Kalweit G.A., Feindt P., Micek M., Gams E., and Hellstern P. Markers of activated hemostasis and fibrinolysis in patients with pulmonary malignancies: comparison of plasma levels in central venous and pulmonary venous blood. Thromb Res 97 3 (2000) 105-111
18. Kolomansky A., Hoffman R., Sarig G., Brenner B., and Haim N. Prospective evaluation of patients hospitalized with venous thromboembolism: comparison between cancer and non-cancer patients. Isr Med Assoc J 8 12 (2006) 848-852
19. Mulligan M.S., Polley M.J., Bayer R.J., Nunn M.F., Paulson J.C., and Ward P.A. Neutrophil-dependent acute lung injury. Requirement for P-selectin (GMP-140). J Clin Invest 90 (1992) 1600-1607
20. Watine J. Prognostic impact of an activation of coagulation in lung cancer. Ann Oncol 9 11 (1998) 1255-1256
21. Mason D.P., Quader M.A., Blackstone E.H., Rajeswaran J., DeCamp M.M., Murthy S.C., Quader A.K., and Rice T.W. Thromboembolism after pneumonectomy for malignancy: an independent marker of poor outcome. J Thorac Cardiovasc Surg 131 3 (2006) 711-718
22. Bergqvist D., Agnelli G., Cohen A.T., Eldor A., Nilsson P.E., Le Moigne-Amrani A., Dietrich-Neto F., and ENOXACAN II Investigators. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 346 (2002) 975-980
23. Rasmussen M.S., Jorgensen L.N., Wille-Jørgensen P., Nielsen J.D., Horn A., Mohn A.C., Sømod L., Olsen B., and FAME Investigators. Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study. J Thromb Haemost 4 11 (2006) 2384-2390